NeurogesX

Develops and commercializes therapies for chronic peripheral neuropathic pain.

Launch date

1998

Employees

Market cap

Enterprise valuation

San Carlos California (HQ)

Date	Investors	Amount	Round
-	Alta Partners ARCH Venture Partners Global Life Science Ventures Walden International Montreux Equity Partners Diamond Capital Management TIAA Grove Street Advisors	N/A	-
May 2007	N/A	N/A	IPO
Jan 2008	SV Health Investors	$25.0m	Post IPO Equity
Aug 2011	SV Health Investors	$20.2m	Post IPO Equity
Mar 2012	N/A	$980k	Seed
Jul 2013*	Acorda Therapeutics	N/A	Acquisition
Total Funding		€79.3m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about NeurogesX